151 related articles for article (PubMed ID: 18240283)
1. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease.
Simondi D; Mengozzi G; Betteto S; Bonardi R; Ghignone RP; Fagoonee S; Pellicano R; Sguazzini C; Pagni R; Rizzetto M; Astegiano M
Inflamm Bowel Dis; 2008 May; 14(5):645-51. PubMed ID: 18240283
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
3. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
6. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
Ben-Shachar S; Finezilber Y; Elad H; Rabinowitz K; Goren I; Isakov O; Yanai H; Dotan I
Inflamm Bowel Dis; 2019 Jan; 25(2):336-344. PubMed ID: 30265311
[TBL] [Abstract][Full Text] [Related]
8. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
10. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of antibodies anti-saccharomyces cerevisiae (ASCA) and autoantibodies in patients with inflammatory bowel disease].
Beltrão M; Bodas A; Azevedo F; Nunes A; Santos C; Delgado L
Acta Med Port; 2010; 23(5):829-36. PubMed ID: 21144323
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
13. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center.
Gupta A; Derbes C; Sellin J
Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
15. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.
Halfvarson J; Standaert-Vitse A; Järnerot G; Sendid B; Jouault T; Bodin L; Duhamel A; Colombel JF; Tysk C; Poulain D
Gut; 2005 Sep; 54(9):1237-43. PubMed ID: 15863472
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
[TBL] [Abstract][Full Text] [Related]
18. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
19. Serological markers in inflammatory bowel diseases.
Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
[TBL] [Abstract][Full Text] [Related]
20. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker?
Sostegni R; Daperno M; Ercole E; Rigazio C; Bresso F; Masoero G; Castellino F; Zaffino C; Rocca R; Molinaro GC; Rocca G; Astegiano M; Pera A
Dig Liver Dis; 2001 Dec; 33(9):755-61. PubMed ID: 11838610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
